Skip to main content
Equibles
ATXI logo

ATXI · Avenue Therapeutics, Inc. · Share Buybacks

Track ATXI — free

Use ATXI with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ATXI.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.38 -0.05 (-10.71%) At close · Mar 19
Rebalance outlook locked
Going-concern doubt — flagged Aug 7, 2026

Substantial doubt about the company's ability to continue as a going concern.

“These factors individually and collectively cause substantial doubt about the Company's ability to continue as a going concern to exist within one year from the date of this report.”
View the 10-Q filed Aug 7, 2026
Market Cap
$848,783
Shares
3.29M
Volume · Mar 19 173.84K Avg daily vol (3M) 426.7K

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Repurchase History

Fiscal Year Ended Cash Spent
2023-12-31 $0
2022-12-31 $1,104,000
Key facts CIK 1644963 CUSIP 05360L403 Visit website Investor relations